Elizabeth Berry-Kravis is professor of child neurology at Rush University Medical Center in Chicago.
Elizabeth Berry-Kravis
Professor
Rush University Medical Center
From this contributor
Analysis offers new hope for failed fragile X drug
Eye tracking shows that mavoglurant, a once-abandoned experimental drug for fragile X syndrome, enters the brain and boosts social interest, says Elizabeth Berry-Kravis.
Analysis offers new hope for failed fragile X drug
By
Jessica Wright
26 February 2019 | 6 min read
Questions for Elizabeth Berry-Kravis: Dodging mouse traps
A mouse model of fragile X syndrome lacks a key feature of the condition, prompting researchers to look for other ways to test treatments.
Questions for Elizabeth Berry-Kravis: Dodging mouse traps
By
Jessica Wright
24 May 2016 | 6 min read
Questions for Elizabeth Berry-Kravis: Measuring drug effects
Drugs designed to treat fragile X syndrome have yet to show substantial benefits in people. But rather than abandon them, child neurologist Elizabeth Berry-Kravis suggests a new way to measure their effectiveness.
Questions for Elizabeth Berry-Kravis: Measuring drug effects
By
Nicholette Zeliadt
17 February 2015 | 5 min read
Explore more from The Transmitter
David Sussillo on persistence, luck and the bonds between life and work
In a Q&A about his new book, “Emergence,” Sussillo shares why he wrote it and how challenging circumstances shaped his journey into neuroscience.
David Sussillo on persistence, luck and the bonds between life and work
In a Q&A about his new book, “Emergence,” Sussillo shares why he wrote it and how challenging circumstances shaped his journey into neuroscience.
By
Francisco J. Rivera Rosario, David Sussillo
17 March 2026 | 7 min watch
Leucovorin, long-read sequencing, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 March.
Leucovorin, long-read sequencing, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 March.
By
Jill Adams
17 March 2026 | 2 min read
Large-scale neuroimaging datasets often lack information specific to women’s health, constraining AI’s analysis potential
Addressing this gap will require collecting widespread data on pregnancy, menopause and other life events women experience—and could bring us closer to the “holy grail” of linking brain and behavior.
Large-scale neuroimaging datasets often lack information specific to women’s health, constraining AI’s analysis potential
Addressing this gap will require collecting widespread data on pregnancy, menopause and other life events women experience—and could bring us closer to the “holy grail” of linking brain and behavior.
By
Amy Kuceyeski
16 March 2026 | 0 min watch